https://www.selleckchem.com/products/ms1943.html
The frequent coexistence of multimorbidity, polypharmacy and geriatric syndromes in this patient group requires individually tailored interventions to preserve patient independence and overall functioning. To prepare for the changing demography, rheumatologists should gain more insight into the implications of multimorbidity, polypharmacy and geriatric syndromes for the management of older patients with inflammatory rheumatic diseases. Response to immune checkpoint blockade (IC in ovarian cancer remains disappointing. Several studies h
Like
Comment
Share
